IPO Premiums
IPO calendar
NCListed

Nephro Care India Limited

Book Built Issue IPO · NSE

Price band
₹85 - ₹90
Lot size
1,600 shares
Issue amount
₹41.26 cr
Total subscription
770.15×
Current price₹89.5
Listing price ₹171
Watch live price ↗
Opens
28 Jun 2024
Closes
2 Jul 2024
Allotment
3 Jul 2024
Listing
5 Jul 2024

Offer at a glance

Issue overview

Issue size
45,84,000 shares
Face value
₹10 Per Equity Share
Minimum investment
₹1,36,000
Fresh issue
₹41.26 cr
Offer for sale
₹0 cr
Registrar
Bigshare Services Private Limited
Listing exchange
NSE
Maximum investment
₹1,44,000
Issue type
Book Built Issue IPO
Shares before issue
1,19,02,400
Shares after issue
1,64,86,400

Lot sizes

CategoryLotsSharesAmount
RETAIL11,600₹1,44,000
HNI23,200₹2,88,000

Share reservation

Retail31.52%
NII(HNI)13.51%
QIB18.01%
Market Maker5.03%

Subscription & GMP

Subscription by category

Total subscribed770.15×

Missing multiples are calculated from bids and offered shares when available.

QIB245.14×
NIB1,787.56×
RETAIL634.12×

GMP history

087.51756 Mar: ₹17514 Nov: ₹17526 Nov: ₹175
6 Mar₹17526 Nov

Application-wise demand

CategoryReserved applicationsApplied applications
——

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs7.431,821.48
RETAIL138,245.6

Financial performance

Company financials

in ₹ Lakhs · Reported periods may include interim results.

Revenue & profitin ₹ Lakhs
-50005001,0001,5002,000Mar-21 · Revenue: 183.26Mar-21 · Profit after tax: 8.87Mar-21Mar-22 · Revenue: 342.7Mar-22 · Profit after tax: -0.98Mar-22Mar-23 · Revenue: 1,709.51Mar-23 · Profit after tax: 194.24Mar-23Dec-23 · Revenue: 1,989.6Dec-23 · Profit after tax: 340.04Dec-23
RevenueProfit after tax

Key performance indicators

Metric Dec-23 Mar-23 Mar-22
EPS3.361.94-0.03
ROE41.57132.46-3.84
ROCE36.5671.094.13
RONW24.4279.68-1.98
PRE IPO(PE)55.1500
POST IPO(PE)32.7300

Values and labels as reported in the issue data.

Company information

Company profile

Nephro Care India Limited, incorporated in 2014 and based in Kolkata, is a specialized treatment center focusing on renal insufficiency and comprehensive clinical and lifestyle solutions. Supported by expert doctors, paramedical professionals, and a skilled management team, the hospital serves approximately 900 Chronic Kidney Disease patients monthly. Operating from a 5,352 sq. ft. main clinic in Salt Lake and three satellite clinics in Salt Lake (HB 113) and Chandannagar, West Bengal, Nephro Care employs 110 staff members, including 5 permanent doctors, 10 visiting consultants, and 70 paramedical professionals. The center offers a wide range of services, including an in-house Dialysis Unit, outpatient services in nephrology, diabetology, cardiology, ophthalmology, and neurology, an NABL-accredited in-house pathology, a pharmacy, advanced diagnostics, a renal nutrition department, home care, the Mukti Lifestyle Support Program, and home dialysis services.

Strengths

  • Regulatory Compliance Risks: The healthcare sector is subject to stringent regulations, and any failure to comply with applicable laws could lead to legal and financial repercussions.
  • High Operational Costs: Maintaining advanced medical technology and skilled professionals requires significant investment, which could impact profitability if not managed effectively.
  • Patient Dependency: The company's revenue heavily relies on patient volume, and any decline due to changing healthcare policies, competition, or patient preferences could negatively affect business performance.

Risk factors

  • Location Dependency: All clinics are in Kolkata, with a major part of the company's revenue coming from the Salt Lake clinic. This makes the business sensitive to any local economic or political changes.
  • Expansion Risks: The company's plan to expand into new areas like setting up a hospital could bring fresh challenges and higher risks.
  • Reliance on Healthcare Professionals: The business heavily depends on its doctors and healthcare staff. Difficulty in attracting or retaining skilled professionals in the future could negatively impact its operations and growth.

Promoters

Dr. Pratim Sengupta

Registrar & documents

Lead manager

Corporate Capitalventures Private Limited

Registered office

Flat No-1JC-18, 5th Floor Sec-III, Salt lake Kolkata, Bidhan Nagar Sai Complex, North 24 Parganas -700098

+91 8017010197

[email protected]/Company website ↗

Frequently Asked Questions

What is Nephro Care India IPO GMP today?

As of today, Nephro Care India IPO Grey Market Premium (GMP) is reported at +₹175 per share. Based on the upper price band of ₹90, the estimated listing price is ₹265 (+194.4% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Nephro Care India IPO?

The minimum bid lot size for Nephro Care India IPO is 1,600 shares. At the cut-off price of ₹90 per share, retail investors need a minimum application amount of ₹1,44,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Nephro Care India IPO allotment status be announced?

The allotment status for Nephro Care India IPO is scheduled to be finalized on 3 Jul 2024. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Nephro Care India IPO allotment status online by PAN?

To check Nephro Care India IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Nephro Care India Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.